ClinStar to Present on Russia's Performance as an Emerging Market in Global Clinical Trials
SAN FRANCISCO, Sept. 15, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today that Manager of Clinical Operations Alexander Kutermin will speak at VIBpharma's Outsourcing in Clinical Trials New England conference, September 28-29, at The Boston Park Plaza Hotel & Towers in Boston, MA.
(Logo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO)
The paradigm of traditional drug development is shifting as more and more pharmaceutical and biotech organizations look to emerging markets to reduce their clinical study timelines, and hence overall development costs, through more effective patient enrollment. During the presentation scheduled for Wednesday, September 28 at 3:00 p.m., Mr. Kutermin will explore perceptions of emerging markets, evaluate Russia's clinical trial climate in comparison to other emerging countries and learn how to navigate Russia's regulations in order to ensure study success. The presentation will feature a real-life case study evaluating Russia's performance compared to two other regions in a global phase II clinical trial.
VIBpharma's Outsourcing in Clinical Trials New England conference prides itself in offering an expertly designed intelligence and networking platform to discuss pressing industry issues and provide practical solutions to the greatest challenges in clinical outsourcing. With more than 25 sessions, pharmaceutical and biotechnology participants at this year's conference will discuss unparalleled partnership strategies; value propositions in vendor selection; innovative methods to optimize patient enrollment; regulatory challenges; profitable budget management, trial costing and alternative pricing structures; expanded clinical development; emerging markets; and best practices for heightened vigilance in outsourced clinical trials.
About ClinStar, LLC
ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.
SOURCE ClinStar, LLC